Lacrimal gland ductal carcinomas: Clinical, Morphological and Genetic characterization and implications for targeted treatment

Ductal carcinomas (DCs) of the lacrimal gland are very rare but aggressive malignancies. We investigated DC of the lacrimal gland for potentially clinically actionable targets in the search for new therapeutic options.

[1]  Z. Gatalica,et al.  Apocrine Carcinoma , 2019, Definitions.

[2]  B. Esmaeli,et al.  Current treatment of lacrimal gland carcinoma , 2016, Current opinion in ophthalmology.

[3]  P. Homøe,et al.  The interleukin‐6/Janus kinase/STAT3 pathway in pleomorphic adenoma and carcinoma ex pleomorphic adenoma of the lacrimal gland , 2016, Acta ophthalmologica.

[4]  M. Gilbert,et al.  A 20-Year Review of 75 Cases of Salivary Duct Carcinoma. , 2016, JAMA otolaryngology-- head & neck surgery.

[5]  C. Caldas,et al.  Expression of androgen receptor splice variants in clinical breast cancers , 2015, Oncotarget.

[6]  Chong Ka Lung,et al.  A benign presentation of primary ductal adenocarcinoma of lacrimal gland: A rare malignancy , 2015, Indian journal of ophthalmology.

[7]  I. Wessel,et al.  Activation of the interleukin‐6/Janus kinase/STAT3 pathway in pleomorphic adenoma of the parotid gland , 2015, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[8]  Simion I. Chiosea,et al.  Molecular Characterization of Apocrine Salivary Duct Carcinoma , 2015, The American journal of surgical pathology.

[9]  X. Teng,et al.  GCDFP-15, AR, and Her-2 as biomarkers for primary ductal adenocarcinoma of the lacrimal gland: a Chinese case and literature review , 2015, OncoTargets and therapy.

[10]  T. Dennie.  Metastatic, Her-2 Amplified Lacrimal Gland Carcinoma with Response to Lapatinib Treatment , 2015, Case reports in oncological medicine.

[11]  D. Amadori,et al.  Single bone metastasis from adenocarcinoma of the lacrimal gland: a case report. , 2014, Future oncology.

[12]  W. Kim,et al.  Primary Ductal Adenocarcinoma of the Lacrimal Gland, associated with Abundant Intracytoplasmic Lumens containing Some Eosinophilic Hyaline Globules: Cytological, Histological and Ultrastructural Findings , 2014, Ultrastructural pathology.

[13]  F. Tavassoli,et al.  Androgen receptor (AR) expression in 400 breast carcinomas: is routine AR assessment justified? , 2014, American journal of cancer research.

[14]  John M S Bartlett,et al.  Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. , 2014, Archives of pathology & laboratory medicine.

[15]  John M S Bartlett,et al.  Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Andres Forero,et al.  Phase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast Cancer , 2013, Clinical Cancer Research.

[17]  Simion I. Chiosea,et al.  PIK3CA Mutations and PTEN Loss in Salivary Duct Carcinomas , 2013, The American journal of surgical pathology.

[18]  Raphaël Porcher,et al.  Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15 , 2013, Breast Cancer Research.

[19]  S. Heegaard,et al.  Epithelial tumours of the lacrimal gland: a clinical, histopathological, surgical and oncological survey , 2013, Acta ophthalmologica.

[20]  S. Ichihara,et al.  Clinicopathologic and immunohistochemical features of primary ductal adenocarcinoma of lacrimal gland: five new cases and review of literature , 2013, Graefe's Archive for Clinical and Experimental Ophthalmology.

[21]  R. Tishler,et al.  Trastuzumab for the treatment of salivary duct carcinoma. , 2013, The oncologist.

[22]  Julie M. Batten,et al.  Detection of Novel Actionable Genetic Changes in Salivary Duct Carcinoma Helps Direct Patient Treatment , 2012, Clinical Cancer Research.

[23]  Y. Jun,et al.  Primary Adenocarcinoma of the Lacrimal Gland , 2012, Archives of plastic surgery.

[24]  Y. Tsutsumi.  Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma. , 2012, Japanese journal of clinical oncology.

[25]  T. Ettl,et al.  Loss of PTEN is associated with elevated EGFR and HER2 expression and worse prognosis in salivary gland cancer , 2012, British Journal of Cancer.

[26]  P. Slootweg,et al.  Androgen receptor-positive salivary duct carcinoma: a disease entity with promising new treatment options. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  Anthony Rhodes,et al.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. , 2010, Archives of pathology & laboratory medicine.

[28]  Anthony Rhodes,et al.  American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  Nicholas B. Levine,et al.  Malignant mixed tumor of the lacrimal gland in a teenager. , 2010, Journal of pediatric ophthalmology and strabismus.

[30]  J. Jonas,et al.  Epithelial tumors of the lacrimal gland in the Chinese: a clinicopathologic study of 298 patients , 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.

[31]  M. Ohji,et al.  Case of ductal adenocarcinoma ex pleomorphic adenoma of the lacrimal gland. , 2009, Rinsho byori. The Japanese journal of clinical pathology.

[32]  Y. Oh,et al.  Primary ductal adenocarcinoma of the lacrimal gland , 2009, Japanese Journal of Ophthalmology.

[33]  A. Holodny,et al.  Novel management and unique metastatic pattern of primary ductal adenocarcinoma of the lacrimal gland , 2008, Clinical & experimental ophthalmology.

[34]  G. Mills,et al.  Improved classification of breast cancer by analysis of genetic alterations and gene expression profiling , 2011 .

[35]  H. Minato,et al.  Cystic carcinoma ex pleomorphic adenoma of the lacrimal gland. , 2007, Ophthalmic plastic and reconstructive surgery.

[36]  C. Shields,et al.  Primary ductal adenocarcinoma of the lacrimal gland. , 2005, Ophthalmology.

[37]  Y. Shibayama,et al.  A case of primary ductal adenocarcinoma of the lacrimal gland: histopathological and immunohistochemical study. , 2005, Pathology, research and practice.

[38]  N. Subramanian,et al.  Primary ductal adenocarcinoma of the lacrimal gland in a patient with neurofibromatosis , 2003, Eye.

[39]  Lyndsay N Harris,et al.  Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  J. R. Reeves,et al.  Evaluating HER2 amplification and overexpression in breast cancer , 2001, The Journal of pathology.

[41]  C. Moskaluk,et al.  Analysis of chromosome 9p21 deletion and p16 gene mutation in salivary gland carcinomas. , 1999, Human pathology.

[42]  A. Huvos,et al.  Epithelial tumors of the lacrimal glands: a clinicopathologic study. , 1999, Annals of diagnostic pathology.

[43]  S. Pambuccian,et al.  Salivary Duct Carcinoma , 1998, Acta Cytologica.

[44]  W. Green,et al.  Primary adenocarcinoma of the lacrimal gland. A retrospective study. , 1993, Ophthalmology.

[45]  A. Hornblass,et al.  Mucoepidermoid Carcinoma of the Lacrimal Gland: 25 Cases and a Review and Update of the Literature , 1993, Ophthalmic plastic and reconstructive surgery.

[46]  L. Holbach,et al.  Primary ductal adenocarcinoma of the lacrimal gland: case report. , 2012, Arquivos brasileiros de oftalmologia.

[47]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[48]  L. Plank,et al.  Salivary duct carcinoma--a highly aggressive salivary gland tumor with HER-2/neu oncoprotein overexpression. , 2001, Pathology, research and practice.

[49]  David A. Lee,et al.  A clinicopathologic study of primary adenoid cystic carcinoma of the lacrimal gland. , 1985, Ophthalmology.